| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.726 | 25.653 | 25.497 | 29.943 | 28.755 | 26.889 | 25.494 | 27.537 | 22.946 | 23.467 |
| Total Income - EUR | 26.069 | 25.957 | 25.629 | 30.334 | 29.145 | 28.029 | 25.652 | 27.773 | 23.372 | 23.681 |
| Total Expenses - EUR | 15.711 | 13.901 | 13.631 | 13.139 | 15.063 | 17.562 | 15.041 | 6.353 | 7.119 | 7.241 |
| Gross Profit/Loss - EUR | 10.358 | 12.056 | 11.998 | 17.195 | 14.082 | 10.466 | 10.611 | 21.420 | 16.254 | 16.440 |
| Net Profit/Loss - EUR | 9.586 | 11.543 | 11.743 | 16.895 | 13.790 | 10.197 | 9.855 | 20.586 | 13.692 | 13.810 |
| Employees | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Ofta-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.928 | 1.773 | 1.611 | 1.452 | 1.296 | 1.146 | 1.111 | 1.114 | 0 | 0 |
| Current Assets | 9.847 | 10.835 | 10.746 | 16.055 | 15.225 | 10.479 | 9.508 | 37.183 | 14.485 | 17.949 |
| Inventories | 0 | 0 | 0 | 228 | 246 | 241 | 0 | 0 | 0 | 0 |
| Receivables | 539 | 379 | 435 | 689 | 676 | 4.443 | 3.234 | 21.089 | 809 | 11.613 |
| Cash | 9.308 | 10.456 | 10.311 | 15.139 | 14.303 | 5.795 | 6.274 | 16.094 | 13.677 | 6.336 |
| Shareholders Funds | 9.824 | 11.779 | 11.974 | 17.122 | 14.013 | 10.416 | 10.068 | 20.801 | 13.905 | 14.022 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 1.951 | 830 | 383 | 385 | 2.508 | 1.210 | 551 | 17.497 | 580 | 3.927 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ofta-Med S.r.l.